Research
Adherence
Early slow responders to bariatric surgery (low EWL at 3 months) should be identified through routine monitoring and offered intensified interventions, including pharmacologic support like GLP-1 receptor agonists.
If you are losing weight slower than expected in the first 3 months, talk to your doctor. You may be a 'slow responder,' and this is a known risk factor. Your team can offer extra support, such as dietary counseling, behavioral therapy, or medications like GLP-1 agonists, to help you get back on track.
ModerateSupportsMEDIUM confidence
For those identified as early slow responders, strategies may include intensified nutritional counseling, structured behavioral interventions, and pharmacologic therapies such as GLP-1 receptor agonists [20,53].
Why this rating
Based on narrative review of clinical pathways and some studies.
Source
Clinical Significance of Early Postoperative Weight Loss in Bariatric Surgery: A Narrative Review
Su Mi Kim · Journal of Metabolic and Bariatric Surgery · 2025
DOI 10.17476/jmbs.2025.14.2.139
narrative_reviewCited 2×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Achieving ≥20–25% early postoperative weight loss (EWL) within the first 3–6 months after bariatric surgery strongly predicts sustained long-term weight loss (≥50% EWL) and metabolic remission.Good
- Bariatric surgery induces rapid hormonal changes (increased GLP-1, PYY, decreased ghrelin) and bile acid signaling that drive early satiety and metabolic improvements, independent of caloric restriction.Good
Related findings · Adherence
- Regular physical activity (at least 150 minutes/week of moderate-intensity) reduces all-cause and cardiovascular mortality by 20-30% and lowers the risk of type 2 diabetes by 25-35%.Strong
- Increasing physical activity from a sedentary lifestyle to an active one in middle adulthood significantly reduces the risk of coronary events compared to remaining sedentary.Strong
- Resistance exercise is the only intervention capable of consistently restoring muscle function and strength in sarcopenia, partially overcoming age-related anabolic resistance.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →